Acknowledgements
Breast Cancer
ONCOLOGY, BREAST CANCER
The authors would like to extend thanks to all patients, clinicians, and nurses for their efforts in this study. This work was supported by Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Shanghai, China), grants from the National Key R&D Project of China (2020YFA0112304), the National Natural Science Foundation of China (91959207 and 92159301), the Shanghai Key Laboratory of Breast Cancer (12DZ2260100), the Shanghai Key Clinical Specialty of Oncology (shslczdzk02001), the Clinical Research Plan of SHDC (SHDC2020CR4002, SHDC2020CR5005), the Natural Science Foundation of Shanghai (21ZR1414700) and the SHDC Municipal Project for Developing Emerging and Frontier Technology in Shanghai Hospitals (SHDC12021103).